First Trust NYSE Arca Biotechnology Index Fund (FBT)

NYSEArca Currently up 2.59 (+0.97%) in today's trading session

1 member of Congress has disclosed 7 trades in First Trust NYSE Arca Biotechnology Index Fund (FBT) via STOCK Act filings. The most recent disclosure was a sale by Michael K. Simpson on 2 February 2016. Aggregate disclosed activity totals roughly $40K in purchases and $65K in sales (midpoint estimates from bracketed disclosure amounts).

First Trust NYSE Arca Biotechnology Index Fund is currently trading at $270.74, positioned at 96% of its 52-week range ($173.98 – $274.99).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$270.74
24h Change
+2.59 (+0.97%)
52 Week Range
$173.98$274.99
View on NASDAQ

First Trust NYSE Arca Biotechnology Index Fund Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for FBT

Select to highlight on chart
5 transactions
Compliance: 29%
Michael K. Simpson2 Feb 201615 Mar 2017SaleStock$15,001 - $50,000N/A
Michael K. Simpson2 Feb 201614 May 2017SaleStock$15,001 - $50,000N/A
Michael K. Simpson21 Sept 201511 Oct 2015PurchaseStock$1,001 - $15,000N/A
Michael K. Simpson21 Sept 201513 May 2016PurchaseStock$1,001 - $15,000N/A
Michael K. Simpson21 Sept 20154 Aug 2016PurchaseStock$1,001 - $15,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$1.68B

Volume

14.92K

Beta

0.76

P/E Ratio

29.53

Fundamentals

EPS

$9.15

Div. Yield

-

Open

$270.78

Day Range

$270.00 – $271.20

Company Information

Sector
Financial Services
Industry
Asset Management
Exchange
AMEX · USD
Country
US
IPO Date
2006-06-23

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund (ETF) designed with a clear purpose: to accurately reflect the price movements and income generated by the NYSE Arca Biotechnology Index. Its core objective is to clo...

No earnings data available for this stock.

Dividends

Dividend History

13 Dec 2024
Amount $1.1726
30 Dec 2021
Amount $2.2140
23 Sept 2015
Amount $0.0200
24 Jun 2015
Amount $0.0650
25 Mar 2015
Amount $0.0480
23 Dec 2014
Amount $0.0524
23 Jun 2008
Amount $0.2697

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about FBT

Which members of Congress have traded FBT?
1 member of Congress has disclosed 7 trade in First Trust NYSE Arca Biotechnology Index Fund (FBT) under the STOCK Act: Michael K. Simpson.
When was FBT most recently disclosed by Congress?
The most recent FBT disclosure was a sale by Michael K. Simpson on 2 February 2016.
What is the total disclosed congressional trading volume for FBT?
Members of Congress have disclosed approximately $40K in FBT purchases and $65K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in FBT?
This FBT page updates as soon as new STOCK Act disclosures are filed for First Trust NYSE Arca Biotechnology Index Fund. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.